1. Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway
   Wei Zhou et al, 2017, Front. Mol. Neurosci. CrossRef
2. Isomahanine induces endoplasmic reticulum stress and simultaneously triggers p38 MAPK-mediated apoptosis and autophagy in multidrug-resistant human oral squamous cell carcinoma cells
   Tanyarath Utaipan et al, 2017 CrossRef
3. Effect of fluorinated tetrahydrocarbazole derivatives on the enzymes of oxidative deamination of biogenic amines and on the process of lipid peroxidation
   N. S. Nikolaeva et al, 2017, Russ Chem Bull CrossRef
4. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response.
   Sabine Hombach-Klonisch et al, 2018, Pharmacol Ther CrossRef
5. Non-apoptotic Cell Death in Malignant Tumor Cells and Natural Compounds
   Jing Ye et al, 2018, Cancer Letters CrossRef
6. Endothelial Monocyte-Activating Polypeptide-II Induces BNIP3-Mediated Mitophagy to Enhance Temozolomide Cytotoxicity of Glioma Stem Cells via Down-Regulating MiR-24-3p
   Jian Zhang et al, 2018, Front. Mol. Neurosci. CrossRef
7. Pyranocarbazole derivatives as potent anti-cancer agents triggering tubulin polymerization stabilization induced activation of caspase-dependent apoptosis and downregulation of Akt/mTOR in breast cancer cells
   Om P.S. Patel et al, 2019, European Journal of Medicinal Chemistry CrossRef
8. Design, synthesis, DNA binding studies and evaluation of anticancer potential of novel substituted biscarbazole derivatives against human glioma U87 MG cell line
   Nitin Kuma et al, 2020, Bioorganic Chemistry CrossRef
9. G protein‑coupled estrogen receptor/miR‑148a/human leukocyte antigen‑G signaling pathway mediates cell apoptosis of ovarian endometriosis
   Shun He et al, 2018, Mol Med Report CrossRef
10. null
    Sang Y. Lee et al, 2021 CrossRef
11. null
    Sanaz Dastghaib et al, 2021 CrossRef
12. Fundamental signaling pathways for glioblastoma drug resistance and developing robust organoid models for drug discovery
    Athira Pratap et al, 2022, Organoid CrossRef
13. Is Autophagy Inhibition in Combination with Temozolomide a Therapeutically Viable Strategy?
    Ahmed M. Elshazly et al, 2023, Cells CrossRef
14. null
    Carla Varela et al, 2023 CrossRef
15. Advances in Glioblastoma Multiforme: Integrating Therapy and Pathology Perspectives
    Seyed Hossein Shahcheraghi et al, 2024, Pathology - Research and Practice CrossRef
16. Selective regulation of chemosensitivity in glioblastoma by phosphatidylinositol 3-kinase beta
    Kevin J. Pridham et al, 2024, iScience CrossRef
17. Programmed cell death disrupts inflammatory tumor microenvironment (TME) and promotes glioblastoma evolution
    Tingyu Liang et al, 2024, Cell Commun Signal CrossRef